The primary outcome in this study was the change in total quality-of-life scores from baseline to week 24 after patients were randomly assigned to a treatment group.
70% of severely mentally ill patients on Medicaid were not tested for diabetes, despite having a two to three times greater risk.
Guidelines, however, say that antipsychotics should only be used short term for severe psychotic symptoms and agitation.
PDP patients treated with antipsychotics were four times as likely to died following three to six months of treatment than those not on the meds.
Dementia patients who were younger, female and lived in nursing homes were most associated with psychotropic polypharmacy.
Rexulti (brexpiprazole), from Otsuka and Lundbeck, is approved as a monotherapy in schizophrenia and an adjunct in patients with major depression.
Almost 60% of people diagnosed with a first episode of psychosis were also smokers.
WHO identifies over 700 adverse event reports from Africa of patients taking what they thought was diazepam but was actually haloperidol.
Patients with late life schizophrenia who had their antipsychotic dose reduced had fewer side effects without sacrificing medication efficacy.
Males were more likely to be given antipsychotics than females, and among young adults given the drugs, depression was most common diagnosis.
Parkinson's patients who took any antipsychotic were more than twice as likely to die within 180 days than those not on one.
Invega Trinza is dosed once every four months following monthly treatment of Invega Sustenna for at least four months.
One psychiatrist is calling on authorities to declassify psychedelic drugs to study their therapeutic potential for mental illnesses.
Patients taking a long-acting injectable antipsychotic had better medication adherence and control of symptoms than peers taking a pill version.
In survey, patients with schizophrenia and psychiatrists both expressed displeasure over efficacy and side effects of current antipsychotics.
PD psychosis is underreported and faces treatment challenges, though a new treatment on the horizon may change that.
A group of psychiatric associations is recommending that behavioral changes and other nonpharmacological interventions be used instead.
However, researchers found no weight gain in children and adolescents who took SSRI and SNRI antidepressants.
An study of people convicted of homicides found that using benzodiazepines was associated with a 45% increased risk of doing so.
A Phase II trial of Intra-Cellular's ITI-007 shows improvement in negative symptoms of schizophrenia without side effects seen in other antipsychotics.
One Danish scientist argues that the benefits of psychiatric drugs have been exaggerated and their harms minimized.
Invega Trinza, from Janssen, should be available to patients by mid-June.
Ongoing research indicates that biomarkers can predict the efficacy of an antipsychotic or potential side effects in a patient.
An evaluation of the CATIE trial finds high lipid levels may boost cognition in schizophrenia patients.
Measuring levels of cortisol and inflammation markers may help to determine if a patient will respond to an antipsychotic.
Abilify (aripiprazole) has annual sales of nearly $8 billion.
Brexpiprazole, thought to be a successor to aripiprazole (Abilify), could be approved by the FDA for schizophrenia in July.
Analysis of data from preschoolers on Medicaid shows nearly 1.2% of them received a prescription for ADHD, anxiety or depression.
Although clozapine is often ignored by many clinicians, the antipsychotic should be considered for more patients.
ALKS 3831, developed by Alkermes, shows efficacy on par with olanzapine, but without the weight gain.
Psychiatry Advisor Articles
- Sport Psychiatry: An Emerging Specialty
- Clinical Hypnosis May Be Effective for Cancer Pain, IBS, Headaches
- Electroconvulsive Therapy Continues to Be Vital Treatment for Depression in Elderly
- Prolactin-Related Symptoms Decrease with Reduced Risperidone Dosage
- Psilocybin May Provide Swift Relief From Depression, Anxiety in Cancer Patients
- Physical Activity During Midlife Influences Late Life Verbal Memory Performance
- Children With ADHD May Adapt More Poorly To Changes In Positive Reinforcement Patterns
- "Drunkorexia" Linked To Both Eating and Substance Use Disorders
- Updated Depression Screening Recommendations for Adults
- ADHD Symptoms in Adulthood Vary Based on Work Environment
- SPECT Imaging Offers More Accurate Diagnosis of Traumatic Brain Injury
- Medical Students at High Risk for Depression, Suicidal Ideation
- Acute Coronary Syndrome Patients Demonstrate Higher Risk of Suicide
- Psychoeducation No More Effective Than Peer Support at Reducing Time to Next Bipolar Episode
- No Difference Between Omega-3 & Placebo in Patients at Ultrahigh Risk for Psychosis